title: Dominant rearrangements among human tumor-infiltrating lymphocytes. Analysis of T-cells derived from 32 patients with melanoma, lung, and renal cell carcinoma.
abstract: Dominant rearrangements of T-cell receptor (TCR) beta-chain genes are reported among tumor-infiltrating lymphocytes (TIL). After interleukin-2 expansion of TIL from renal and lung carcinoma and melanoma biopsy tissues, rearrangements of TCR beta-chain genes were analyzed by Southern blotting. Nongermline restriction fragments, indicating dominant rearrangements, were detected among the TIL from all 6 patients with renal cell carcinoma, 17 of 20 patients with melanoma, and 3 of 6 patients with lung tumors. The restriction-fragment sizes of these dominant rearrangements were heterogeneous among the various patients. Rearrangements into C beta 1 were more common than C beta 2 rearrangements. Phenotypic analyses indicated that dominant rearrangements occurred in both CD4 and CD8 predominant TIL populations. The TIL populations that were extracted were expanded to derive large cell numbers suitable for in vivo transfer in an interleukin-2 and TIL immunotherapy program. The data indicated that the cells delivered to these patients usually were characterized by dominant populations of T-cells with selective TCR gene rearrangements. The significance of selective TCR use requires evaluation of the function and specificity of the TIL comprising these dominant populations both in their native in vivo setting and in the context of therapeutic transfer.
authors.affiliation: Department of Pathology, Harvard Medical School, Massachusetts General Hospital, Boston.
authors.forename: W T
authors.initials: WT
authors.lastname: Bennett
authors.forename: F
authors.initials: F
authors.lastname: Pandolfi
authors.forename: B H
authors.initials: BH
authors.lastname: Grove
authors.forename: G E
authors.initials: GE
authors.lastname: Hawes
authors.forename: L A
authors.initials: LA
authors.lastname: Boyle
authors.forename: R L
authors.initials: RL
authors.lastname: Kradin
authors.forename: J T
authors.initials: JT
authors.lastname: Kurnick
mesh_terms: D002283:Carcinoma, Bronchogenic / Q000235:genetics / Q000473:pathology; D002292:Carcinoma, Renal Cell / Q000235:genetics / Q000473:pathology; D015333:Gene Rearrangement, beta-Chain T-Cell Antigen Receptor / Q000235:genetics*; D005799:Genes, Dominant / Q000235:genetics*; D006801:Humans; D007680:Kidney Neoplasms / Q000235:genetics / Q000473:pathology; D008175:Lung Neoplasms / Q000235:genetics / Q000473:pathology; D016246:Lymphocytes, Tumor-Infiltrating / Q000502:physiology*; D008545:Melanoma / Q000235:genetics / Q000473:pathology; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology; D010641:Phenotype; D013601:T-Lymphocytes / Q000502:physiology*